 |
 | Vissza |
Zielinski Christoph; Láng István; Beslija Semir; Kahán Zsuzsanna; Inbar Moshe J.; Stemmer Salomon M.; Anghel Rodica; Vrbanec Damir; Messinger Diethelm; Brodowicz Thomas:
Predictive role of hand-foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer.
BRITISH JOURNAL OF CANCER, 114.
pp. 163-170.
ISSN 0007-0920
(2016)
Brodowicz Thomas; Láng István; Kahán Zsuzsanna; Greil R.; Beslija Semir; Stemmer Salomon M.; Kaufman B.; Petruzelka L.; Eniu A.; Anghel Rodica; Koynov K.; Vrbanec Damir; Pieńkowski Tadeusz; Melichar B.; Spanik S.; Ahlers S.; Messinger Diethelm; Inbar Moshe J.; Zielinski Christoph:
Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses.
BRITISH JOURNAL OF CANCER, 111 (11).
pp. 2051-2057.
ISSN 0007-0920
(2014)
Nikolényi Alíz; Sükösd Farkas; Kaizer László; Csörgő Erika; Vörös András; Uhercsák Gabriella; Ormándi Katalin; Lázár György, ifj.; Thurzó László; Brodowicz Thomas; Kahán Zsuzsanna:
Tumor topoisomerase II alpha status and response to anthracycline-based neoadjuvant chemotherapy in breast cancer.
Oncology, 80 (3-4).
pp. 269-277.
ISSN 0030-2414
(2011)
